Modern Diagnostic & Research Centre Current Share Price | Modern Diagnostic & Research Centre Stock Screener
MDRC
Healthcare Service Provider
Modern Diagnostic & Research Centre Current Stock Price Today
Track the current Modern Diagnostic & Research Centre share price and stock price live with TickJournal's free stock screener.
Browse MDRC balance sheet details to support your investment research.
Use the Modern Diagnostic & Research Centre stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Modern Diagnostic & Research Centre Market Cap
₹121.54 Cr.
MDRC P/E Ratio (TTM)
-
Modern Diagnostic & Research Centre P/B Ratio
2.22
EPS (TTM)
₹3.48
Dividend Yield
-
Debt to Equity
1.31
MDRC 52 Week High
-
Modern Diagnostic & Research Centre 52 Week Low
-
Operating Margin
-
Profit Margin
-
MDRC Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹119.00
Total Equity
₹59.00
Modern Diagnostic & Research Centre Current Share Price Chart
Track the current Modern Diagnostic & Research Centre share price and stock price with an interactive chart. Analyse MDRC price trends, trading volume, historical performance, and volatility across different timeframes — the complete Modern Diagnostic & Research Centre stock quote in one place.
Modern Diagnostic & Research Centre Company Profile - Fundamental Screener
Screen Modern Diagnostic & Research Centre company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for MDRC shares.
Sector
Healthcare
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE1HK501016
Modern Diagnostic & Research Centre Balance Sheet Screener
Screen MDRC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 119 | 65 | 50 | 37 | 49 |
| Current Assets | 43 | 24 | 18 | 12 | 18 |
| Fixed Assets | 58 | 31 | 27 | 24 | 24 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 16 | 12 | 14 | 9 | 17 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 59 | 21 | 12 | 6 | 12 |
| Share Capital | 15 | 11 | 1 | 1 | 1 |
| Reserves & Surplus | 44 | 10 | 11 | 5 | 11 |
Modern Diagnostic & Research Centre Income Statement Screener - Profit & Revenue Analysis
Screen Modern Diagnostic & Research Centre income statement and profit fundamentals.
Analyze MDRC quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Modern Diagnostic & Research Centre share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|---|
| Revenue | 0 | 83 | 79 | 69 | 57 | 61 |
| Expenses | 0 | 71 | 60 | 56 | 57 | 54 |
| EBITDA | 0 | 13 | 19 | 13 | -1 | 6 |
| Operating Profit % | 0.00% | 15.00% | 23.00% | 16.00% | -2.00% | 10.00% |
| Depreciation | 0 | 5 | 4 | 4 | 4 | 4 |
| Interest | 0 | 2 | 2 | 2 | 1 | 2 |
| Profit Before Tax | 0 | 6 | 13 | 7 | -6 | 1 |
| Tax | 0 | 2 | 4 | 1 | 0 | 3 |
| Net Profit | 0 | 4 | 9 | 6 | -6 | -2 |
| EPS | 0.00 | 3.48 | 8.15 | 5.27 | -5.21 | -1.32 |
Modern Diagnostic & Research Centre Cash Flow Screener - Liquidity Fundamentals
Screen MDRC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 14 | 8 | 0 | 4 |
| Investing Activities | -13 | -11 | 2 | -5 |
| Financing Activities | 0 | 3 | -7 | 5 |
| Net Cash Flow | 0 | 0 | -5 | 3 |
Modern Diagnostic & Research Centre Shareholding Pattern Screener
See Modern Diagnostic & Research Centre shareholding pattern with promoter, FII, and DII holdings.
Check Modern Diagnostic & Research Centre promoter holding and ownership changes for MDRC on TickJournal.
| Item | 2026-Jan | 2026-Mar | 2025-Mar | 2025-Dec | 1899-Dec |
|---|---|---|---|---|---|
| Promoter Holding | 72.85% | 72.85% | 100.00% | 100.00% | 72.85% |
| FII Holding | 1.07% | 0.03% | 0.00% | 0.00% | 1.07% |
| DII Holding | 11.80% | 15.48% | 0.00% | 0.00% | 11.80% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 12.82% | 4.75% | 0.00% | 0.00% | 12.82% |
| Other Holding | 1.45% | 6.89% | 0.00% | 0.00% | 1.46% |
| Shareholder Count | 641 | 282 | 7 | 7 | 641 |
Modern Diagnostic & Research Centre Share Dividend Screener - Share Yield Analysis
Check Modern Diagnostic & Research Centre dividend history with payout and yield data.
View Modern Diagnostic & Research Centre dividend details including ex-dates and amounts for MDRC stock.
Modern Diagnostic & Research Centre Stock Index Membership
See which indices include Modern Diagnostic & Research Centre stock.
Check MDRC index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Modern Diagnostic & Research Centre Market Events Screener - Corporate Actions
Get Modern Diagnostic & Research Centre corporate actions including splits, bonuses, and buybacks.
Check Modern Diagnostic & Research Centre stock events that may affect MDRC share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | 74.75% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -1.46% |
Modern Diagnostic & Research Centre Competitors Screener - Peer Comparison
Screen MDRC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 31,798 | 58.53 | 2,864 | 12.11% | 510 | 52.85 |
| Vijaya Diagnostic Centre | 14,360 | 79.29 | 835 | 19.34% | 173 | 44.95 |
| Metropolis Healthcare | 11,818 | 58.52 | 1,671 | 24.15% | 191 | 48.12 |
| Thyrocare Technologies | 8,577 | 49.29 | 846 | 20.48% | 163 | 37.31 |
| Nephrocare Health Services | 7,219 | 86.55 | 1,023 | 32.93% | 77 | 57.75 |
| Krsnaa Diagnostics | 1,732 | 18.02 | 773 | 4.05% | 106 | 43.89 |
| Suraksha Diagnostic | 1,695 | 47.71 | 314 | 22.55% | 31 | 54.61 |
| 3B BlackBio DX | 1,137 | 20.67 | 142 | 27.17% | 61 | 49.35 |
| One Global Service Provider | 989 | 13.73 | 499 | 237.48% | 70 | 39.84 |
| Health X Platform | 970 | -36.56 | 1,319 | 12.68% | -3 | 53.22 |
Modern Diagnostic & Research Centre Company Announcements - News Screener
Screen MDRC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Clarification On Significant Movement In The Price Of The Securities Of The Company | - | |
| Clarification sought from Modern Diagnostic & Research Centre Ltd | - | |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-08 | Reg. 34 (1) Annual Report. | - |
| 2026-09-08 | Revised Letter Attached In The Intimation For 14Th AGM Of The Company | - |
| 2026-09-08 | Revised Date In The Letter Attached For Intimation Of Book Closure | - |
| 2026-09-08 | Revised Date In The Letter Attached For Intimation Of Record Date | - |
| 2026-09-03 | Intimation For The 14Th Annual General Meeting (AGM) And Book Closure | - |
| 2026-09-03 | Intimation For The 14Th Annual General Meeting (AGM) And Book Closure | - |
| 2026-09-03 | Intimation For Record Date | - |
| 2026-09-03 | Intimation Of Appointment Of Scrutinizer Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (LODR) | - |
| 2026-09-03 | Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-26 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-05-29 | Financial Results For The Half Year And Year Ended 31.03.2026 | - |
| 2026-05-29 | Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-28 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-21 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015 | - |
| 2026-05-21 | Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Year Ended 31St March 2026 | - |
| 2026-05-15 | Disclosure Under Regulation 41(4) Of SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018 For The Year Ended 31St March 2026 | - |